Gene expression profiling in anti-CD11d mAb-treated spinal cord-injured rats

Journal of Neuroimmunology

Volumn 209, Issue 1-2, 2009, Pages 104-113

  Gris, Paul ^a,b   Tighe, Allyson ^a,b   Thawer, Sakina ^a,b   Hemphill, Andrew ^a   Oatway, Mark ^a,b   Weaver, Lynne ^a,b   Dekaban, Gregory A ^a,b   Brown, Arthur ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Anti inflammatory; CSPGs; Gene expression profiling; Genomics; Microarray; Spinal cord injury

Indexed keywords

1B7 MONOCLONAL ANTIBODY; CD11D MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICROARRAY ANALYSIS; NERVE GROWTH; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SLOT BLOT HYBRIDIZATION; SPINAL CORD INJURY; WOUND HEALING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11; CICATRIX; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; INFLAMMATION MEDIATORS; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER; SPINAL CORD INJURIES; WOUND HEALING;

EID: 64549119061     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.02.002     Document Type: Article

References (34)

1. Avnur Z., and Geiger B. Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody. Cell 38 (1984) 811-822
2. Bao F., Chen Y., Dekaban G.A., and Weaver L.C. An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats. J. Neurochem. 90 (2004) 1194-1204
3. Bao F., Chen Y., Dekaban G.A., and Weaver L.C. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J. Neurochem. 88 (2004) 1335-1344
4. Bao F., Dekaban G.A., and Weaver L.C. Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J. Neurochem. 94 (2005) 1361-1373
5. Bartholdi D., and Schwab M.E. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 672 (1995) 177-186
6. Blight A.R. Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9 Suppl. 1 (1992) S83-91
7. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., and McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416 (2002) 636-640
8. Carmel J.B., Galante A., Soteropoulos P., Tolias P., Recce M., Young W., and Hart R.P. Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. Physiol. Genomics 7 (2001) 201-213
9. De Biase A., Knoblach S.M., Di Giovanni S., Fan C., Molon A., Hoffman E.P., and Faden A.I. Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. Physiol. Genomics 22 (2005) 368-381
10. Devalaraja M.N., and Richmond A. Multiple chemotactic factors: fine control or redundancy?. Trends Pharmacol. Sci. 20 (1999) 151-156
11. Fawcett J.W., and Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 49 (1999) 377-391
12. Fehlings M.G., and Tator C.H. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132 (1995) 220-228
13. Geissmann F., Jung S., and Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003) 71-82
14. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev., Immunol. 5 (2005) 953-964
15. Gotting C., Kuhn J., Zahn R., Brinkmann T., and Kleesiek K. Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J. Mol. Biol. 304 (2000) 517-528
16. Grimpe B., and Silver J. A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. J. Neurosci. 24 (2004) 1393-1397
17. Gris D., Marsh D.R., Oatway M.A., Chen Y., Hamilton E.F., Dekaban G.A., and Weaver L.C. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J. Neurosci. 24 (2004) 4043-4051
18. Gris P., Tighe A., Levin D., Sharma R., and Brown A. Transcriptional regulation of scar gene expression in primary astrocytes. Glia 55 (2007) 1145-1155
19. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev., Immunol. 8 (2008) 533-544
20. Hausmann O.N. Post-traumatic inflammation following spinal cord injury. Spinal Cord 41 (2003) 369-378
21. Kerstens H.M., Poddighe P.J., and Hanselaar A.G. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J. Histochem. Cytochem. 43 (1995) 347-352
22. Kigerl K.A., Lai W., Rivest S., Hart R.P., Satoskar A.R., and Popovich P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 102 (2007) 37-50
23. Lee Y.L., Shih K., Bao P., Ghirnikar R.S., and Eng L.F. Cytokine chemokine expression in contused rat spinal cord. Neurochem. Int. 36 (2000) 417-425
24. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004) 677-686
25. McEwen M.L., and Springer J.E. A mapping study of caspase-3 activation following acute spinal cord contusion in rats. J. Histochem. Cytochem. 53 (2005) 809-819
26. Morgenstern D.A., Asher R.A., and Fawcett J.W. Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137 (2002) 313-332
27. Popovich P.G., Guan Z., Wei P., Huitinga I., van Rooijen N., and Stokes B.T. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158 (1999) 351-365
28. Popovich P.G., Guan Z., McGaughy V., Fisher L., Hickey W.F., and Basso D.M. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. 61 (2002) 623-633
29. Popovich P.G., van Rooijen N., Hickey W.F., Preidis G., and McGaughy V. Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp. Neurol. 182 (2003) 275-287
30. Saville L.R., Pospisil C.H., Mawhinney L.A., Bao F., Simedrea F.C., Peters A.A., O'Connell P.J., Weaver L.C., and Dekaban G.A. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment. J. Neuroimmunol. 156 (2004) 42-57
31. Taoka Y., and Okajima K. Spinal cord injury in the rat. Prog. Neurobiol. 56 (1998) 341-358
32. Velardo M.J., Burger C., Williams P.R., Baker H.V., Lopez M.C., Mareci T.H., White T.E., Muzyczka N., and Reier P.J. Patterns of gene expression reveal a temporally orchestrated wound healing response in the injured spinal cord. J. Neurosci. 24 (2004) 8562-8576
33. Wiksten M., Vaananen A.J., Liebkind R., and Liesi P. Regeneration of adult rat spinal cord is promoted by the soluble KDI domain of gamma1 laminin. J. Neurosci. Res. 78 (2004) 403-410
34. Yamauchi S., Mita S., Matsubara T., Fukuta M., Habuchi H., Kimata K., and Habuchi O. Molecular cloning and expression of chondroitin 4-sulfotransferase. J. Biol. Chem. 275 (2000) 8975-8981